Serial measurement of hFABP and high-sensitivity troponin I post-PCI in STEMI: How fast and accurate can myocardial infarct size and no-reflow be predicted?

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 305, Issue 7, 2013, Pages

  Uitterdijk, André ^a   Sneep, Stefan ^a   van Duin, Richard W B ^a   Krabbendam Peters, Ilona ^a   Gorsse Bakker, Charlotte ^a   Duncker, Dirk J ^a   van der Giessen, Willem J ^a   van Beusekom, Heleen M M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Acute myocardial infarction; Heart specific fatty acid binding protein; High sensitivity troponin I; Markers of myocardial necrosis; No reflow; STEMI model

Indexed keywords

FATTY ACID BINDING PROTEIN; HEART SPECIFIC FATTY ACID BINDING PROTEIN; HIGH SENSITIVITY TROPONIN I; TRIPHENYLTETRAZOLIUM; TROPONIN I; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CORONARY ARTERY BLOOD FLOW; FEMALE; HEART HEMODYNAMICS; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HEART RATE; HEART VENTRICLE FIBRILLATION; KIDNEY CLEARANCE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REPERFUSION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

ACUTE MYOCARDIAL INFARCTION; HEART-SPECIFIC FATTY ACID BINDING PROTEIN; HIGH-SENSITIVITY TROPONIN I; MARKERS OF MYOCARDIAL NECROSIS; NO REFLOW; STEMI MODEL;

ANIMALS; BIOLOGICAL MARKERS; CORONARY CIRCULATION; DISEASE MODELS, ANIMAL; FATTY ACID-BINDING PROTEINS; FEMALE; HEMODYNAMICS; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; MYOCARDIUM; NECROSIS; NO-REFLOW PHENOMENON; PREDICTIVE VALUE OF TESTS; RISK FACTORS; STAINING AND LABELING; SWINE; TETRAZOLIUM SALTS; THIAZOLES; TIME FACTORS; TROPONIN I; UP-REGULATION;

EID: 84884911958     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00447.2013     Document Type: Article

References (36)

1. Aldous S, Pemberton C, Troughton R, Than M, Mark Richards A. Heart fatty acid binding protein and myoglobin do not improve early rule out of acute myocardial infarction when highly sensitive troponin assays are used. Resuscitation 83: e27-e28; author reply e29-e30, 2012.
2. Arai AE. Magnetic resonance imaging for area at risk, myocardial infarction, and myocardial salvage. J Cardiovasc Pharmacol Ther 16: 313-320, 2011.
3. Body R, McDowell G, Carley S, Wibberley C, Ferguson J, Mackway-Jones K. A FABP-ulous "rule out" strategy? Heart fatty acid binding protein and troponin for rapid exclusion of acute myocardial infarction. Resuscitation 82: 1041-1046, 2011.
4. Carroll C, Al Khalaf M, Stevens JW, Leaviss J, Goodacre S, Collinson PO, Wang J. Heart-type fatty acid binding protein as an early marker for myocardial infarction: systematic review and meta-analysis. Emerg Med J 30: 280-286, 2013.
5. Chia S, Senatore F, Raffel OC, Lee H, Wackers FJ, Jang IK. Utility of cardiac biomarkers in predicting infarct size, left ventricular function, and clinical outcome after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. JACC Cardiovasc Interv 1: 415-423, 2008.
6. Collinson PO. Republished: sensitive troponin assays. Postgrad Med J 88: 348-352, 2012.
7. Dekker MS, Mosterd A, van't Hof AW, Hoes AW. Novel biochemical markers in suspected acute coronary syndrome: systematic review and critical appraisal. Heart 96: 1001-1010, 2010.
8. Delanghe JR, De Buyzere ML, Cluyse LP, Thierens HM, Clement DL. Acute myocardial infarction size and myoglobin release into serum. Eur J Clin Chem Clin Biochem 30: 823-830, 1992.
9. Duncker DJ, Klassen CL, Ishibashi Y, Herrlinger SH, Pavek TJ, Bache RJ. Effect of temperature on myocardial infarction in swine. Am J Physiol Heart Circ Physiol 270: H1189-H1199, 1996.
10. Ellis AK, Little T, Zaki Masud AR, Klocke FJ. Patterns of myoglobin release after reperfusion of injured myocardium. Circulation 72: 639-647, 1985.
11. Giannitsis E, Steen H, Kurz K, Ivandic B, Simon AC, Futterer S, Schild C, Isfort P, Jaffe AS, Katus HA. Cardiac magnetic resonance imaging study for quantification of infarct size comparing directly serial versus single time-point measurements of cardiac troponin T. J Am Coll Cardiol 51: 307-314, 2008.
12. Gillis JM, Dunselman P, Jarausch J, de Jong N, Cobbaert CM. Preanalytical storage does not affect 99th percentile cardiac troponin T concentrations measured with a high-sensitivity assay. Clin Chem 59: 442-443, 2013.
13. Glatz JF, van Bilsen M, Paulussen RJ, Veerkamp JH, van der Vusse GJ, Reneman RS. Release of fatty acid-binding protein from isolated rat heart subjected to ischemia and reperfusion or to the calcium paradox. Biochim Biophys Acta 961: 148-152, 1988.
14. Hale SL, Dae MW, Kloner RA. Hypothermia during reperfusion limits "no-reflow" injury in a rabbit model of acute myocardial infarction. Cardiovasc Res 59: 715-722, 2003.
15. Hale SL, Herring MJ, Kloner RA. Delayed treatment with hypothermia protects against the no-reflow phenomenon despite failure to reduce infarct size. J Am Heart Assoc 2: e004234, 2013.
16. Hale SL, Kloner RA. Cardioprotection with adenosine-regulating agent, GP531: effects on no-reflow, infarct size, and blood flow following ischemia/reperfusion in the rabbit. J Cardiovasc Pharmacol Ther 15: 60-67, 2010.
17. Haltern G, Peiniger S, Bufe A, Reiss G, Gulker H, Scheffold T. Comparison of usefulness of heart-type fatty acid binding protein versus cardiac troponin T for diagnosis of acute myocardial infarction. Am J Cardiol 105: 1-9, 2010.
18. Hedstrom E, Astrom-Olsson K, Ohlin H, Frogner F, Carlsson M, Billgren T, Jovinge S, Cain P, Wagner GS, Arheden H. Peak CKMB and cTnT accurately estimates myocardial infarct size after reperfusion. Scand Cardiovasc J 41: 44-50, 2007.
19. Kagawa Y, Toyofuku M, Masaoka Y, Muraoka Y, Okimoto T, Otsuka M, Tamekiyo H, Mito S, Kawase T, Yamane K, Senoo A, Amioka M, Shiode N, Hayashi Y. Comparison of heart-type fatty acid binding protein and sensitive troponin for the diagnosis of early acute myocardial infarction. Int J Cardiol 166: 347-351, 2013.
20. Kahn P, Aldor E. [Serum myoglobin and myocardial infarction (author's transl)]. Wien Klin Wochenschr 92: 538-540, 1980.
21. Kakoti A, Goswami P. Heart type fatty acid binding protein: structure, function and biosensing applications for early detection of myocardial infarction. Biosens Bioelectron 43: 400-411, 2013.
22. Katus HA, Giannitsis E. Who is David and who is Goliath? There is an urgent need to improve the reference standards for estimation of myocardial infarct size. JACC Cardiovasc Imaging 4: 534-536, 2011.
23. Klein HH, Schubothe M, Nebendahl K, Kreuzer H. Temporal and spatial development of infarcts in porcine hearts. Basic Res Cardiol 79: 440-447, 1984.
24. Liao J, Chan CP, Cheung YC, Lu JH, Luo Y, Cautherley GW, Glatz JF, Renneberg R. Human heart-type fatty acid-binding protein for on-site diagnosis of early acute myocardial infarction. Int J Cardiol 133: 420-423, 2009.
25. Matsumoto S, Nakatani D, Sakata Y, Suna S, Shimizu M, Usami M, Hara M, Sumitsuji S, Nanto S, Sasaki T, Hamasaki T, Sato H, Hori M, Komuro I; Osaka Acute Coronary Insufficiency Study (OACIS) Group. Elevated serum heart-type fatty acid-binding protein in the convalescent stage predicts long-term outcome in patients surviving acute myocardial infarction. Circ J 77: 1026-1032, 2013.
26. McCann CJ, Glover BM, Menown IB, Moore MJ, McEneny J, Owens CG, Smith B, Sharpe PC, Young IS, Adgey JA. Investigation of a multimarker approach to the initial assessment of patients with acute chest pain. Adv Ther 26: 531-534, 2009.
27. Ndrepepa G, Tiroch K, Fusaro M, Keta D, Seyfarth M, Byrne RA, Pache J, Alger P, Mehilli J, Schomig A, Kastrati A. 5-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction. J Am Coll Cardiol 55: 2383-2389, 2010.
28. Pelsers MM, Hermens WT, Glatz JF. Fatty acid-binding proteins as plasma markers of tissue injury. Clin Chim Acta 352: 15-35, 2005.
29. Reffelmann T, Kloner RA. Microvascular reperfusion injury: rapid expansion of anatomic no reflow during reperfusion in the rabbit. Am J Physiol Heart Circ Physiol 283: H1099-H1107, 2002.
30. Reiter M, Twerenbold R, Reichlin T, Mueller M, Hoeller R, Moehring B, Haaf P, Wildi K, Merk S, Bernhard D, Mueller CZ, Freese M, Freidank H, Campodarve Botet I, Mueller C. Heart-type fatty acidbinding protein in the early diagnosis of acute myocardial infarction. Heart 99: 708-714, 2013.
31. Ruff CT, Bonaca MP, Kosowsky JM, Conrad MJ, Murphy SA, Jarolim P, Donahoe SM, O'Donoghue ML, Morrow DA. Evaluation of the diagnostic performance of heart-type fatty acid binding protein in the BWH-TIMI ED chest pain study. J Thromb Thrombolysis 2013.
32. Schwartz BG, Kloner RA. Coronary no reflow. J Mol Cell Cardiol 52: 873-882, 2012.
33. Sodha NR, Clements RT, Feng J, Liu Y, Bianchi C, Horvath EM, Szabo C, Sellke FW. The effects of therapeutic sulfide on myocardial apoptosis in response to ischemia-reperfusion injury. Eur J Cardiothorac Surg 33: 906-913, 2008.
34. 2+-saturated form. Nature 424: 35-41, 2003.
35. van den Besselaar AM, Witteveen E, van der Meer FJ. Long-term stability of frozen pooled plasmas stored at-70°C,-40°C, and-20°C for prothrombin time and International Normalized Ratio (INR) assessment. Thromb Res 131: 349-351, 2013.
36. Vrints CJ. Pathophysiology of the no-reflow phenomenon. Acute Card Care 11: 69-76, 2009.